Lynn James

449 total citations
11 papers, 280 citations indexed

About

Lynn James is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Lynn James has authored 11 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 4 papers in Physiology and 4 papers in Psychiatry and Mental health. Recurrent topics in Lynn James's work include Botulinum Toxin and Related Neurological Disorders (9 papers), Cerebral Palsy and Movement Disorders (3 papers) and Neurological disorders and treatments (3 papers). Lynn James is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (9 papers), Cerebral Palsy and Movement Disorders (3 papers) and Neurological disorders and treatments (3 papers). Lynn James collaborates with scholars based in United States, Canada and Ireland. Lynn James's co-authors include Mitchell F. Brin, Terry Boodhoo, George Demos, Henry Chrystyn, Nina Eadie, Janice M. Pogoda, Amanda M. VanDenburgh, Ross Zafonte, Markus Naumann and Susan Abushakra and has published in prestigious journals such as Neurology, Journal of the American Academy of Dermatology and Movement Disorders.

In The Last Decade

Lynn James

7 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn James United States 4 209 86 74 48 34 11 280
Angelika Hanschmann Germany 12 476 2.3× 114 1.3× 39 0.5× 197 4.1× 17 0.5× 35 565
Kwang-Won Yum South Korea 5 132 0.6× 29 0.3× 62 0.8× 19 0.4× 11 0.3× 18 179
Nedim Sarıfakioğlu Türkiye 8 55 0.3× 29 0.3× 47 0.6× 25 0.5× 5 0.1× 15 245
A. Richardson United Kingdom 5 315 1.5× 68 0.8× 15 0.2× 115 2.4× 4 0.1× 5 381
Juan Ramirez‐Castaneda United States 5 269 1.3× 63 0.7× 18 0.2× 81 1.7× 2 0.1× 7 296
Saskia Rohrbach‐Volland Germany 5 248 1.2× 113 1.3× 17 0.2× 45 0.9× 11 0.3× 6 307
Victor Ricardo Manuel Muñoz-Lora Brazil 8 268 1.3× 158 1.8× 31 0.4× 29 0.6× 27 410
P.H. Jongerius Netherlands 7 237 1.1× 45 0.5× 8 0.1× 44 0.9× 7 0.2× 9 292
Hyewon Hu South Korea 12 225 1.1× 42 0.5× 192 2.6× 20 0.4× 33 332
Gao Zeng China 9 52 0.2× 14 0.2× 28 0.4× 15 0.3× 10 0.3× 37 202

Countries citing papers authored by Lynn James

Since Specialization
Citations

This map shows the geographic impact of Lynn James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn James more than expected).

Fields of papers citing papers by Lynn James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn James. The network helps show where Lynn James may publish in the future.

Co-authorship network of co-authors of Lynn James

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn James. A scholar is included among the top collaborators of Lynn James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn James. Lynn James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Crerand, Canice E., Kristina I. Suorsa, Michelle M. Ernst, et al.. (2025). Stigma in differences of sex development: a scoping review. Journal of Pediatric Psychology. 50(9). 846–869.
2.
Pozo‐Rosich, Patricia, Andrew Blumenfeld, Richard B. Lipton, et al.. (2025). OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial. Cephalalgia. 45(10). 2235415825–2235415825.
3.
Gormley, Mark, Darcy Fehlings, Marcin Bonikowski, et al.. (2024). Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Pediatric Upper and Lower Limb Spasticity: Results From 2 Open-Label, Long-term Extension Trials. Journal of Child Neurology. 40(3). 168–179.
4.
5.
Dimitrova, Rozalina, Lynn James, Chengcheng Liu, et al.. (2020). Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies. CNS Drugs. 34(4). 433–445. 3 indexed citations
6.
Brin, Mitchell F., Suresh Durgam, Lynn James, et al.. (2019). OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females. International Clinical Psychopharmacology. 35(1). 19–28. 39 indexed citations
7.
8.
9.
Naumann, Markus, Alastair Carruthers, Jean Carruthers, et al.. (2010). Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Movement Disorders. 25(13). 2211–2218. 109 indexed citations
10.
Brin, Mitchell F., Terry Boodhoo, Janice M. Pogoda, et al.. (2009). Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants. Journal of the American Academy of Dermatology. 61(6). 961–970.e11. 94 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelika Hanschmann Breakdown of academic impact, for papers by Kwang-Won Yum Breakdown of academic impact, for papers by Nedim Sarıfakioğlu Breakdown of academic impact, for papers by A. Richardson Breakdown of academic impact, for papers by Juan Ramirez‐Castaneda Breakdown of academic impact, for papers by Saskia Rohrbach‐Volland Breakdown of academic impact, for papers by Victor Ricardo Manuel Muñoz-Lora Breakdown of academic impact, for papers by P.H. Jongerius Breakdown of academic impact, for papers by Hyewon Hu Breakdown of academic impact, for papers by Gao Zeng
Rankless by CCL
2026